PYRILAMINE MALEATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pyrilamine Maleate, and what generic alternatives are available?
Pyrilamine Maleate is a drug marketed by Impax Labs and Watson Labs and is included in two NDAs.
The generic ingredient in PYRILAMINE MALEATE is pyrilamine maleate. There are seven drug master file entries for this compound. Additional details are available on the pyrilamine maleate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PYRILAMINE MALEATE?
- What are the global sales for PYRILAMINE MALEATE?
- What is Average Wholesale Price for PYRILAMINE MALEATE?
Summary for PYRILAMINE MALEATE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 61 |
| Patent Applications: | 1,021 |
| DailyMed Link: | PYRILAMINE MALEATE at DailyMed |
Medical Subject Heading (MeSH) Categories for PYRILAMINE MALEATE
US Patents and Regulatory Information for PYRILAMINE MALEATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Impax Labs | PYRILAMINE MALEATE | pyrilamine maleate | TABLET;ORAL | 080808-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | PYRILAMINE MALEATE | pyrilamine maleate | TABLET;ORAL | 085231-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
